Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
5.16
-0.24 (-4.44%)
At close: Apr 28, 2026, 4:00 PM EDT
5.22
+0.06 (1.16%)
After-hours: Apr 28, 2026, 7:51 PM EDT
Cybin Employees
Cybin had 50 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,464,346
Market Cap
258.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus Oncology | 147 |
| Codexis | 146 |
| Arcturus Therapeutics Holdings | 111 |
| C4 Therapeutics | 104 |
| Alector | 103 |
| SAB Biotherapeutics | 86 |
| Compugen | 75 |
| Protara Therapeutics | 46 |
HELP News
- 13 hours ago - Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - GlobeNewsWire
- 5 days ago - Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan - GlobeNewsWire
- 8 days ago - How Trump's psychedelics executive order could unlock stalled cannabis reform - CNBC
- 8 days ago - Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions - GlobeNewsWire
- 8 days ago - Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer - GlobeNewsWire
- 8 days ago - Psychedelic drug makers rally as Trump orders FDA to expedite reviews - Reuters
- 12 days ago - Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs - GlobeNewsWire
- 6 weeks ago - Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer - GlobeNewsWire